Literature DB >> 18456748

Management of cancer pain: ESMO clinical recommendations.

L Jost1, F Roila.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18456748     DOI： 10.1093/annonc/mdn108

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

Review 1.  OROS hydromorphone prolonged release: a review of its use in the management of chronic, moderate to severe pain.

Authors:  Natalie J Carter; Gillian M Keating
Journal:  CNS Drugs       Date:  2010-04       Impact factor: 5.749

2.  Abstral (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain).

Authors: 
Journal:  P T       Date:  2011-02

3.  Cancer Pain Management and Bone Metastases: An Update for the Clinician.

Authors:  Guido Schneider; Raymond Voltz; Jan Gaertner
Journal:  Breast Care (Basel)       Date:  2012-04-27       Impact factor: 2.860

4.  Cancer pain management-current status.

Authors:  Deepak Thapa; V Rastogi; Vanita Ahuja
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.